Literature DB >> 16516781

Presence of mitomycin-C in the anterior chamber after photorefractive keratectomy.

Rodrigo M Torres1, Jesús Merayo-Lloves, Sheraz M Daya, José T Blanco-Mezquita, Marcela Espinosa, Maria J Nozal, José L Bernal, José Bernal.   

Abstract

PURPOSE: To assess the presence of mitomycin-C (MMC) in hen aqueous humor after photorefractive keratectomy (PRK).
SETTING: Instituto Universitario de Oftalmobiología Aplicada, Faculty of Medicine, University of Valladolid, and Department of Analytical Chemistry, Faculty of Sciences, University of Valladolid, Valladolid, Spain.
METHODS: Mitomycin-C 0.02% was applied topically for 2 minutes to a right hen's eye after PRK (Group A) and to the left eye with intact epithelium (Group B). At different time points (10, 30, 60, 360, and 720 minutes), aqueous humor was extracted and high-performance liquid chromatography was performed to detect and quantify MMC levels.
RESULTS: The mean maximum drug concentration of MMC measured in the aqueous humor was 187.250 microg/L +/- 4.349 (SD) in Group A and 93.000 +/- 4.899 microg/L in Group B, both detected 10 minutes after topical application. Statistically significant differences were found between Groups A and B at 10, 30, and 60 minutes, with decreasing MMC levels in both groups but a higher concentration in Group A. After 360 minutes, MMC levels were undetectable in Group B and after 720 minutes in Group A.
CONCLUSIONS: Mitomycin-C was detectable in the aqueous humor of the hen eye after topical application in PRK-treated eyes and in eyes with intact epithelium. The presence of MMC is of concern as it may lead to ocular toxicity in the long term.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16516781     DOI: 10.1016/j.jcrs.2005.06.051

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  7 in total

Review 1.  Impact on the corneal endothelium of mitomycin C during photorefractive keratectomy.

Authors:  Danny S Roh; James L Funderburgh
Journal:  J Refract Surg       Date:  2009-10-12       Impact factor: 3.573

2.  DNA cross-linking, double-strand breaks, and apoptosis in corneal endothelial cells after a single exposure to mitomycin C.

Authors:  Danny S Roh; Amanda L Cook; Steven S Rhee; Amar Joshi; Regis Kowalski; Deepinder K Dhaliwal; James L Funderburgh
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07-24       Impact factor: 4.799

3.  Two-step versus Single Application of Mitomycin-C in Photorefractive Keratectomy for High Myopia.

Authors:  Farhad Fazel; Leila Roshani; Leila Rezaei
Journal:  J Ophthalmic Vis Res       Date:  2012-01

4.  Efficacy of preoperative injection versus intraoperative application of mitomycin in recurrent pterygium surgery.

Authors:  Khaled S Zaky; Yasser M Khalifa
Journal:  Indian J Ophthalmol       Date:  2012-07       Impact factor: 1.848

Review 5.  A Critical Overview of the Biological Effects of Mitomycin C Application on the Cornea Following Refractive Surgery.

Authors:  Esther Arranz-Marquez; Andreas Katsanos; Vassilios P Kozobolis; Anastasios G P Konstas; Miguel A Teus
Journal:  Adv Ther       Date:  2019-03-11       Impact factor: 3.845

6.  One-year outcomes of a bilateral randomised prospective clinical trial comparing PRK with mitomycin C and LASIK.

Authors:  A D Wallau; M Campos
Journal:  Br J Ophthalmol       Date:  2009-11-04       Impact factor: 4.638

7.  Outcomes of photorefractive keratectomy with intraoperative mitomycin-C.

Authors:  Mohammad Ghoreishi; Hossein Attarzadeh; Alireza Zandi; Heidar-Ali Moini; Mehdi Tavakoli; Hamid Fesharaki; Kobra Nasrollahi
Journal:  J Ophthalmic Vis Res       Date:  2009-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.